Image of DXNA logo
  • Contact Us
  • |
  • Careers
    • About DxNA
      • History
      • Mission Statement
    • Executive Team
    • Board of Scientific Advisors
    • Partnering Opportunities
      • Distribution
      • OEM Licensing
      • 3rd Party Integration
    • Careers
    • News & Events
      • DxNA In the News
      • Press Releases
      • Industry Headlines
        • H5N1 - Avian Influenza
        • Malaria
        • Exotic Newcastle DIsease
        • PRRS - Porcine Reproductive and Respiratory Syndrome
        • African Swine Fever
    • Why DxNA
    • Genetic Molecular Analyses
    • Situation Analysis
    • Vital Role of Genetic Testing
    • Overview
    • Biodefense
    • Human Medicine
    • Veterinary Medicine
    • Agriculture
    • Food & Beverage Safety
    • Overview
    • What We Test For
    • Tests & Reagents
    • Request a Test
    • FAQ
    • White Paper
  • Search:
About DxNA
Executive Team
Board of Scientific Advisors
Partnering Opportunities
Careers
News & Events
DxNA In the News
Press Releases
Industry Headlines
H5N1 - Avian Influenza
Malaria
Exotic Newcastle DIsease
PRRS - Porcine Reproductive and Respiratory Syndrome
African Swine Fever

In the News 
 

5/24/2011
United States Patent Office Grants Additional Patent to DxNA for GeneSTAT system
USPTO Awards Patent to DxNA: "Rapid Thermocycler With Movable Assembly"
12/14/2009
FDA Grants Emergency Use Authorization for DxNA’s GeneSTAT(TM) Integrated PCR-based Influenza Detection System for H1N1 Virus
Groundbreaking 4.5kg “Lab in a BoxTM” to Provide Fast H1N1 Virus Detection St. George, UT (December 14, 2009) - DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA’s GeneSTATTM detection platform.
6/9/2009
DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA
DxNA announced today that it has submitted a request to the FDA for Emergency Use Authorization (EUA) for its GeneSTAT® pathogen platform, for the detection of the H1N1 virus (known as swine flu). EUA allows for the early availability of important diagnostic and therapeutics tools to diagnose, treat, or prevent critical or life-threatening diseases or conditions, when an alternative or approved solution is not available.
5/6/2009
DxNA: Mobile H1N1 Test Offers Fast, Accurate Flu Detection
Medpage Today: Medical News: Swine Flu
5/5/2009
DxNA Featured on MSNBC Television: Watch the Video
4/24/2009
DxNA Television News Feature Story
Portable Molecular DIagnostics Can Now Be Performed by Anyone, Anywhere, Rapidly, and Economically: DxNA on KSL-TV, United States
2/22/2009
DxNA News Story on Quick Disease Detection Runs in Top Uganadan Newspaper
“It is the most accurate and sensitive laboratory in a box. It shrinks the most complex procedures that could happen in the most sophisticated laboratory,” Mosman told the press at Sheraton Hotel in Kampala last week. “The device can be operated by anyone, anywhere without prior training on how to use it.”
11/14/2008
DxNA Exhibits GeneSTAT's Groundbreaking
Technology inAvian Influenza Diagnostics and
Global Pandemic Prevention

DxNA was the Platinum Sponsor of the 7th International Bird Flu Summit held in Las Vegas, Nevada (USA) from November 13-14, 2008.
  • site map
  • |
  • privacy
  • |
  • Copyright © 2012 DxNA LLC